Impact on progression-free survival of adjuvant cyclophosphamide, vincristine, doxorubicin (adriamycin), and dacarbazine (CYVADIC) chemotherapy for stage I uterine sarcoma. A prospective trial (Q71933198)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 August 1995
edit
Language Label Description Also known as
English
Impact on progression-free survival of adjuvant cyclophosphamide, vincristine, doxorubicin (adriamycin), and dacarbazine (CYVADIC) chemotherapy for stage I uterine sarcoma. A prospective trial
scientific article published on 01 August 1995

    Statements

    title
    Impact on progression-free survival of adjuvant cyclophosphamide, vincristine, doxorubicin (adriamycin), and dacarbazine (CYVADIC) chemotherapy for stage I uterine sarcoma. A prospective trial (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    7625366
    reference URL
    https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7625366%20AND%20SRC:MED&resulttype=core&format=json
    retrieved
    22 October 2019

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q71933198&oldid=1816263045"